Abstract
Alectinib (Alecensa (R)) is a potent and highly selective anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor. Oral alectinib monotherapy is ap......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
